MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
Haoran Lu,1,* Rou Zhao,2,* Qianqian Qin,3 Liyong Tang,1 Guodong Ma,1 Baoyu He,2 Jing Liang,2 Li Wei,2 Xutong Wang,2 Qingli Bie,2 Xuning Wang,4 Bin Zhang2,5 1Department of Hepatobiliary Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shand...
Main Authors: | Lu H, Zhao R, Qin Q, Tang L, Ma G, He B, Liang J, Wei L, Wang X, Bie Q, Zhang B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-05-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/marcks-is-a-new-prognostic-biomarker-in-hepatocellular-carcinoma-peer-reviewed-fulltext-article-IJGM |
Similar Items
-
Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis
by: Qiannan Gao, et al.
Published: (2022-09-01) -
Identification of Inflammatory Proteomics Networks of Toll-like Receptor 4 through Immunoprecipitation-Based Chemical Cross-Linking Proteomics
by: A. D. A. Shahinuzzaman, et al.
Published: (2022-09-01) -
Role of NCF2 as a potential prognostic factor and immune infiltration indicator in hepatocellular carcinoma
by: Ning Huang, et al.
Published: (2023-04-01) -
Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma
by: Zhonghao Wang, et al.
Published: (2017-07-01) -
Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatment
by: Zhiyuan Zheng, et al.
Published: (2023-08-01)